Robert Petit

Robert Petit has a strong background in the biotechnology and bio-pharmaceutical industries, with a focus on immunotherapy, oncology, autoimmune, and infectious diseases. Robert has held various executive and advisory roles in multiple companies.

From 2010 to 2019, Petit worked at Advaxis, Inc. as the Chief Scientific Officer and Executive Vice President. In this role, they provided executive leadership, determined R&D and corporate strategies, and established the medical and scientific vision of the company. Robert also held the position of Vice President of Clinical Operations and Medical Affairs during this time.

In 2019, Petit served as the Chief Scientific Officer at Carisma Therapeutics and the Chairman of the Scientific Advisory Board at Advaxis.

Starting in 2019, they became the CEO/Principal of RGP Biotech, where they acted as a C-Level Executive, Advisor, and Director for various biotechnology and bio-pharmaceutical companies operating in the immunotherapy, oncology, and autoimmune therapeutic areas.

In 2020, Petit joined HiFiBiO Therapeutics as a Senior Medical/Scientific Advisor, and in 2021, they became a Member of the Scientific Advisory Board at Systems Oncology and an Operations Team Member and Co-Founder at Smart Health Catalyzer.

In 2022, Petit took on the role of Senior Vice President and Head of Early Clinical Development at Orionis Biosciences. Robert also joined Saros Therapeutics as a member of the Scientific Advisory Board.

Throughout their career, Petit has gained experience in various therapeutic areas and technologies, including cytokines, monoclonal antibodies, gene therapy, and innovative drug-device combinations.

Robert Petit attended Indiana State University from an unspecified start year and graduated in 1982 with a Bachelor of Science degree in Life Science. Robert then went on to study at The Ohio State University College of Medicine from 1982 to 1987, although their degree name and field of study during this time period are not provided.